HUE068423T2 - Oritavancin egyszeri adagjai bakteriális fertõzés kezelésére vagy megelõzésére - Google Patents

Oritavancin egyszeri adagjai bakteriális fertõzés kezelésére vagy megelõzésére

Info

Publication number
HUE068423T2
HUE068423T2 HUE15195726A HUE15195726A HUE068423T2 HU E068423 T2 HUE068423 T2 HU E068423T2 HU E15195726 A HUE15195726 A HU E15195726A HU E15195726 A HUE15195726 A HU E15195726A HU E068423 T2 HUE068423 T2 HU E068423T2
Authority
HU
Hungary
Prior art keywords
oritavancin
treating
preventing
bacterial infection
single doses
Prior art date
Application number
HUE15195726A
Other languages
English (en)
Hungarian (hu)
Inventor
Dario Lehoux
Thomas Parr
Gregory Moeck
Pierre Etienne
Original Assignee
The Medicines Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41722337&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE068423(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Medicines Co filed Critical The Medicines Co
Publication of HUE068423T2 publication Critical patent/HUE068423T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
HUE15195726A 2008-08-30 2009-08-29 Oritavancin egyszeri adagjai bakteriális fertõzés kezelésére vagy megelõzésére HUE068423T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9331408P 2008-08-30 2008-08-30
US9349708P 2008-09-02 2008-09-02

Publications (1)

Publication Number Publication Date
HUE068423T2 true HUE068423T2 (hu) 2024-12-28

Family

ID=41722337

Family Applications (3)

Application Number Title Priority Date Filing Date
HUE15195726A HUE068423T2 (hu) 2008-08-30 2009-08-29 Oritavancin egyszeri adagjai bakteriális fertõzés kezelésére vagy megelõzésére
HUE09810708A HUE027373T2 (hu) 2008-08-30 2009-08-29 Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával
HUS1600039C HUS1600039I1 (hu) 2008-08-30 2016-10-06 Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával

Family Applications After (2)

Application Number Title Priority Date Filing Date
HUE09810708A HUE027373T2 (hu) 2008-08-30 2009-08-29 Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával
HUS1600039C HUS1600039I1 (hu) 2008-08-30 2016-10-06 Kezelési eljárások oritavancin egyszeri dózisainak alkalmazásával

Country Status (18)

Country Link
US (1) US8420592B2 (cg-RX-API-DMAC7.html)
EP (3) EP3006038B1 (cg-RX-API-DMAC7.html)
JP (1) JP5782615B2 (cg-RX-API-DMAC7.html)
CN (2) CN102215858A (cg-RX-API-DMAC7.html)
AU (1) AU2009285564B2 (cg-RX-API-DMAC7.html)
CA (1) CA2736860C (cg-RX-API-DMAC7.html)
DK (2) DK3006038T3 (cg-RX-API-DMAC7.html)
EA (1) EA020490B1 (cg-RX-API-DMAC7.html)
ES (2) ES2994966T3 (cg-RX-API-DMAC7.html)
FI (1) FI3006038T3 (cg-RX-API-DMAC7.html)
HU (3) HUE068423T2 (cg-RX-API-DMAC7.html)
MX (1) MX2011002249A (cg-RX-API-DMAC7.html)
NL (1) NL300834I2 (cg-RX-API-DMAC7.html)
NO (1) NO2016019I2 (cg-RX-API-DMAC7.html)
NZ (1) NZ591525A (cg-RX-API-DMAC7.html)
PL (2) PL3006038T3 (cg-RX-API-DMAC7.html)
PT (1) PT3006038T (cg-RX-API-DMAC7.html)
WO (1) WO2010025438A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2424559T3 (pl) * 2009-04-28 2024-07-29 Melinta Therapeutics, Llc Sposoby leczenia zakażeń bakteryjnych z zastosowaniem orytawancyny
WO2014031681A1 (en) * 2012-08-20 2014-02-27 The University Of Chicago Inhibiting gram positive bacteria
WO2014176068A2 (en) * 2013-04-22 2014-10-30 The Medicines Company Treatment and prevention of bacterial skin infections using oritavancin
US20160206688A1 (en) * 2013-08-26 2016-07-21 The Medicines Company Methods for treating bacteremia and osteomyelitis using oritavancin
WO2015031579A2 (en) * 2013-08-28 2015-03-05 The Medicines Company Methods for treating bacterial infections using oritavancin and polymyxins
US20170119793A1 (en) * 2014-06-12 2017-05-04 Cem-102 Pharmaceuticals, Inc. Compositions and methods for treating bone and joint infections
HUE070928T2 (hu) 2014-07-17 2025-07-28 Melinta Therapeutics Llc Nagy tisztaságú oritavancin és eljárás annak elõállítására
BR112018016715A2 (pt) * 2016-02-18 2019-02-19 Melinta Therapeutics, Inc. ?formulações de oritavancina?
US20200171124A1 (en) * 2016-04-15 2020-06-04 Lupin Limited Topical compositions for ophthalmic and otic use
CN108409837B (zh) * 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5994297A (en) * 1997-08-22 1999-11-30 Eli Lilly And Company Therapy for Staphylococcus aureus
IL145582A0 (en) * 1999-05-03 2002-06-30 Lilly Co Eli Monthly doses for treatment of streptococcus pneumoniae infections
ES2316445T3 (es) 2000-05-02 2009-04-16 Theravance, Inc. Composicion que contiene una ciclodextrina y un antibiotico glicopeptidico.
US20030176327A1 (en) * 2001-10-25 2003-09-18 Cassell Gail Houston Antibiotics for treating biohazardous bacterial agents
WO2003102134A2 (en) * 2002-05-28 2003-12-11 Becton, Dickinson And Company Pancreatic acinar cells into insulin producing cells
WO2004017925A2 (en) * 2002-08-23 2004-03-04 Genome Therapeutics Corporation Methods and reagents for preventing bacteremias
US20040127403A1 (en) * 2002-09-06 2004-07-01 Francesco Parenti Methods for treating and preventing Gram-positive bacteremias
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
WO2008097364A2 (en) * 2006-09-25 2008-08-14 Targanta Therapeutics Corp. Use of oritavancin for prevention and treatment of anthrax

Also Published As

Publication number Publication date
EP3006038B1 (en) 2024-07-03
EP2337575A4 (en) 2012-10-17
WO2010025438A9 (en) 2010-05-14
CA2736860A1 (en) 2010-03-04
PT3006038T (pt) 2024-08-23
EP4464375A3 (en) 2025-02-26
JP5782615B2 (ja) 2015-09-24
AU2009285564A1 (en) 2010-03-04
CN106620649A (zh) 2017-05-10
AU2009285564B2 (en) 2014-05-22
PL2337575T3 (pl) 2016-09-30
WO2010025438A2 (en) 2010-03-04
NL300834I2 (cg-RX-API-DMAC7.html) 2016-11-16
NO2016019I1 (no) 2016-10-11
EA020490B1 (ru) 2014-11-28
NO2016019I2 (no) 2019-01-25
PL3006038T3 (pl) 2024-11-12
MX2011002249A (es) 2011-06-24
CN102215858A (zh) 2011-10-12
US20110201546A1 (en) 2011-08-18
EA201100413A1 (ru) 2012-01-30
JP2012501349A (ja) 2012-01-19
US20130172237A1 (en) 2013-07-04
FI3006038T3 (fi) 2024-08-12
EP2337575B1 (en) 2016-04-13
US8420592B2 (en) 2013-04-16
EP2337575A1 (en) 2011-06-29
NZ591525A (en) 2014-03-28
HUE027373T2 (hu) 2016-09-28
DK2337575T3 (en) 2016-05-23
EP3006038A1 (en) 2016-04-13
HUS1600039I1 (hu) 2016-11-28
ES2570401T3 (es) 2016-05-18
ES2994966T3 (en) 2025-02-04
EP4464375A2 (en) 2024-11-20
CA2736860C (en) 2020-04-28
DK3006038T3 (da) 2024-08-26

Similar Documents

Publication Publication Date Title
HUE068423T2 (hu) Oritavancin egyszeri adagjai bakteriális fertõzés kezelésére vagy megelõzésére
PL2326287T3 (pl) Modułowe urządzenie rozprzestrzeniające do leczenia protetycznych zakażeń stawów
ZA200906349B (en) Combination medicaments for treating bacterial infections
ZA201200899B (en) Composition for treating hbv infection
IL219321A0 (en) Methylsulfonylmethane (msm) for treatment of drug resistant microorganisms
EP2273989A4 (en) POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
ZA201300992B (en) Combination therapy for treating hcv infection
ZA201100616B (en) Treatment of antibiotic-resistant bacteria infection
ZA201008192B (en) A phytosystem for treatment of sewage
GB0918841D0 (en) Fibres for infection control
PL2424559T3 (pl) Sposoby leczenia zakażeń bakteryjnych z zastosowaniem orytawancyny
ZA201104669B (en) Implantable devices for treating hiv
IL205035A0 (en) Methods of inhibiting viral infection
IL204940A0 (en) Methods of inhibiting viral infection
GB0815179D0 (en) Medication and treatment for infection
GB0807781D0 (en) Treatment of bacterial infection
HK1171668A (en) Composition for treating hbv infection
GB2442705B (en) Inactivation of gram-positive bacteria
AU2012202689B2 (en) dsRNA for treating viral infection
AU2009900969A0 (en) Treatment of infection
HK1162969A (en) Cyclosporin analogues for preventing or treating hepatitis c infection
ZA201104003B (en) Drug for treating infections
HK1179473A (en) Methods for treating infection
ZA200802123B (en) Benzodiazepine derivatives for treating hepatitis C infection
AU2010901811A0 (en) Avian-Based Treatment for Microbial Infection